2

Accelerated BEP: A phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour

*British Journal of Cancer* 2011; 105(6):766-772

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

*Nature* 2011; 476(7359):214-219

Optimal primary surgical treatment for advanced epithelial ovarian cancer

*Cochrane Database of Systematic Reviews* 2011; 8:CD007565

Hepatitis E virus coinfection in patients with HIV infection

Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma

*Cochrane Database of Systematic Reviews* 2011; 5:CD003911

Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapy

*European Journal of Cancer* 2011; 47(10):1556-1563

Adjuvant progestagens for endometrial cancer

*Cochrane Database of Systematic Reviews* 2011; 6:CD001040

Evaluation of follow‐up strategies for patients with epithelial ovarian cancer following completion of primary treatment

*Cochrane Database of Systematic Reviews* 2011; 6:CD006119

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers

*Biochem J* 2011; 436(3):671-679

Interventions targeted at women to encourage the uptake of cervical screening

*Cochrane Database of Systematic Reviews* 2011; 5:CD002834